Korro Bio, Inc. Other Comprehensive Income, Other, Net of Tax
Korro Bio, Inc. (KRRO) reported Other Comprehensive Income, Other, Net of Tax of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeOtherNetOfTax · last filed 2025-11-12
- Korro Bio, Inc. other comprehensive income, other, net of tax for the quarter ending 2025-09-30 was $0.00.
- Korro Bio, Inc. other comprehensive income, other, net of tax for the quarter ending 2025-06-30 was $0.00.
- Korro Bio, Inc. other comprehensive income, other, net of tax for the quarter ending 2025-03-31 was $0.00.
- Korro Bio, Inc. other comprehensive income, other, net of tax for the quarter ending 2024-09-30 was $0.00.
| Period end | Other Comprehensive Income, Other, Net of Tax 3 month | Other Comprehensive Income, Other, Net of Tax 6 month | Other Comprehensive Income, Other, Net of Tax 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 derived: sum of 3 quarters · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-11-12 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |